Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jellinger

Showing results (251-260 of 364) with videos related to

Pageof 37
Sort By:
Acta Neuropathologica|December 5, 1997
Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementiaC Bancher, R Egensperger, S Kösel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Cortical and brain stem hyperexcitability in a pathologically confirmed case of multiple system atrophyM Kofler, G K Wenning, W Poewe, et al.
Journal of Neural Transmission. Supplementum|January 1, 1978
Dopamine-sensitive adenylate cyclase activity in the caudate nucleus and adrenal medulla in Parkinson's disease and in liver cirrhosisP Riederer, W D Rausch, W Birkmayer, et al.
Journal of Neurochemistry|January 1, 1988
Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agentsW D Rausch, Y Hirata, T Nagatsu, et al.
Journal of Neurochemistry|March 1, 1991
Selective increase of iron in substantia nigra zona compacta of parkinsonian brainsE Sofic, W Paulus, K Jellinger, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's diseaseK Jellinger, L Linert, E Kienzl, et al.
Journal of Neural Transmission|January 1, 1978
Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administrationG P Reynolds, P Riederer, M Sandler, et al.
Journal of Neural Transmission. Supplementum|January 1, 1978
CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathiesP Riederer, W D Rausch, W Birkmayer, et al.
Archives of Neurology|August 26, 1998
Pharmacological therapy in progressive supranuclear palsyK Kompoliti, C G Goetz, I Litvan, et al.
Brain Pathology (Zurich, Switzerland)|July 21, 1998
The Austrian FFI casesH Budka, G Almer, J A Hainfellner, et al.
Pageof 37

Showing results (251-260 of 364) with videos related to

Sort By:
Pageof 37
Acta Neuropathologica|December 5, 1997
Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementiaC Bancher, R Egensperger, S Kösel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Cortical and brain stem hyperexcitability in a pathologically confirmed case of multiple system atrophyM Kofler, G K Wenning, W Poewe, et al.
Journal of Neural Transmission. Supplementum|January 1, 1978
Dopamine-sensitive adenylate cyclase activity in the caudate nucleus and adrenal medulla in Parkinson's disease and in liver cirrhosisP Riederer, W D Rausch, W Birkmayer, et al.
Journal of Neurochemistry|January 1, 1988
Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agentsW D Rausch, Y Hirata, T Nagatsu, et al.
Journal of Neurochemistry|March 1, 1991
Selective increase of iron in substantia nigra zona compacta of parkinsonian brainsE Sofic, W Paulus, K Jellinger, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's diseaseK Jellinger, L Linert, E Kienzl, et al.
Journal of Neural Transmission|January 1, 1978
Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administrationG P Reynolds, P Riederer, M Sandler, et al.
Journal of Neural Transmission. Supplementum|January 1, 1978
CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathiesP Riederer, W D Rausch, W Birkmayer, et al.
Archives of Neurology|August 26, 1998
Pharmacological therapy in progressive supranuclear palsyK Kompoliti, C G Goetz, I Litvan, et al.
Brain Pathology (Zurich, Switzerland)|July 21, 1998
The Austrian FFI casesH Budka, G Almer, J A Hainfellner, et al.
Pageof 37